Conversely, induced pluripotent stem cell–derived cardiomyocytes from patients with Dravet syndrome due to SCN1A mutations have abnormal contractility (68). The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.